{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T04:39:10Z","timestamp":1722919150966},"reference-count":0,"publisher":"National Institute of Public Health NIH (National Research Institute)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Przegl Epidemiol"],"abstract":"<p><strong>ABSTRACT<\/strong><br \/><strong>BACKGROUND.<\/strong> Mumps is a highly infectious viral disease, the source of infection is an infected person. In\u00a02003, compulsory vaccination against mumps was introduced in Poland, carried out according to a two-dose\u00a0schedule. The combined MMR vaccine (against measles, mumps and rubella) is used as part of the Protective\u00a0Vaccination Program (PVP). Mumps vaccination has led to a significant reduction in the incidence of mumps\u00a0in Poland<br \/><strong>AIM.<\/strong> The aim of the study was to evaluate the epidemiological indicators of mumps in Poland in 2019 compared\u00a0to previous years.<br \/><strong>METHODS.<\/strong> The analysis of the epidemiological situation of mumps in Poland in 2019 was based on the\u00a0interpretation of data from the bulletin \u201cInfectious diseases and poisonings in Poland in 2019\u201d and \u201cVaccinations\u00a0in Poland in 2019\u201d.<br \/><strong>RESULTS.<\/strong> In 2019, 1,338 mumps cases were registered in Poland. The total incidence was 3.5 per 100,000\u00a0inhabitants and was lower compared to 2018. The highest incidence 4.6 per 100,000 inhabitants were registered\u00a0in the Opolskie Voivodeship and the lowest \u2013 2.5 in the Podkarpackie Voivodeship. The incidence was the\u00a0highest among 6-year-olds and amounted to 32.3\/100,000. Comparing the differences between the sexes, the\u00a0incidence of men (4.1\/100,000) was higher than that of women (2.9). In 2019, 22 patients were hospitalized due\u00a0to mumps in Poland, which was less than in 2018 (28). The level of mumps vaccination in children at 3 years of\u00a0age was lower by 0.3% compared to 2018 and amounted to 92.6% in Poland.<br \/><strong>CONCLUSIONS.<\/strong> Maintaining a high percentage of children vaccinated against mumps will provide sustaining\u00a0decline in cases of mumps in the coming years.<\/p>\n<p><strong>STRESZCZENIE<\/strong><br \/><strong>WST\u0118P.<\/strong> \u015awinka to choroba wirusowa o du\u017cej zaka\u017ano\u015bci, kt\u00f3rej \u017ar\u00f3d\u0142em zaka\u017cenia jest osoba zaka\u017cona.<br \/>W 2003 r. w Polsce wprowadzono obowi\u0105zkowe szczepienia przeciw \u015bwince, wykonywane wed\u0142ug dwudawkowego\u00a0schematu. W ramach Programu Szczepie\u0144 Ochronnych (PSO) stosowana jest szczepionka skojarzona\u00a0MMR (przeciw odrze, \u015bwince i r\u00f3\u017cyczce). Szczepienia przeciw \u015bwince doprowadzi\u0142y do istotnego obni\u017cenia\u00a0zapadalno\u015bci na \u015bwink\u0119 w Polsce.<br \/><strong>CEL PRACY.<\/strong> Celem pracy by\u0142a ocena wska\u017anik\u00f3w epidemiologicznych dotycz\u0105cych \u015bwinki w Polsce w 2019 r.\u00a0w por\u00f3wnaniu do lat wcze\u015bniejszych.<br \/><strong>MATERIA\u0141 I METODY.<\/strong> Analiz\u0119 sytuacji epidemiologicznej \u015bwinki w Polsce w roku 2019 przeprowadzono\u00a0na podstawie interpretacji danych z biuletynu ,,Choroby zaka\u017ane i zatrucia w Polsce w 2019 roku\u201d oraz ,,Szczepienia\u00a0ochronne w Polsce w 2019 roku\u201d.<br \/><strong>WYNIKI.<\/strong> W 2019 r. w Polsce zarejestrowano 1 338 zachorowa\u0144 na \u015bwink\u0119. Zapadalno\u015b\u0107 og\u00f3\u0142em wynios\u0142a 3,5\u00a0na 100 tys. mieszka\u0144c\u00f3w i by\u0142a ni\u017csza w por\u00f3wnaniu z rokiem 2018. Najwy\u017csz\u0105 zapadalno\u015b\u0107 4,6 na 100 tys.\u00a0mieszka\u0144c\u00f3w zarejestrowano w wojew\u00f3dztwie opolskim, a najni\u017csz\u0105 \u2013 2,5 w woj. podkarpackim. Najcz\u0119\u015bciej\u00a0chorowa\u0142y dzieci w wieku 6 lat \u2013 zapadalno\u015b\u0107 w tej grupie wieku wynosi\u0142a 32,3\/100 tys. Por\u00f3wnuj\u0105c r\u00f3\u017cnice\u00a0mi\u0119dzy p\u0142ciami, zapadalno\u015b\u0107 m\u0119\u017cczyzn (4,1\/100 tys.) by\u0142a wy\u017csza ni\u017c kobiet (2,9\/100 tys.). W 2019 roku w Polsce\u00a0z powodu \u015bwinki hospitalizowano 22 chorych, mniej ni\u017c w 2018 r. (28). Stan zaszczepienia przeciw \u015bwince\u00a0dzieci w 3 roku \u017cycia by\u0142 mniejszy o 0,3% w por\u00f3wnaniu do 2018 roku i wynosi\u0142 92,6% w skali ca\u0142ej Polski.<br \/><strong>WNIOSKI.<\/strong> Utrzymanie wysokiego odsetka zaszczepionych dzieci przeciw \u015bwince zapewni podtrzymanie\u00a0spadku zachorowa\u0144 na zapalenie nagminne przyusznic (\u015bwink\u0119 ) w przysz\u0142ych latach.<\/p><\/jats:p>","DOI":"10.32394\/pe.75.21","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T13:42:52Z","timestamp":1635169372000},"page":"229-234","source":"Crossref","is-referenced-by-count":1,"title":["Mumps in Poland in 2019"],"prefix":"10.32394","volume":"75","author":[{"given":"J","family":"Bogusz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Rosolak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Paradowska-Stankiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17323","published-online":{"date-parts":[[2021,10,15]]},"container-title":["Przeglad Epidemiologiczny"],"original-title":["\u015awinka w Polsce w 2019 roku"],"link":[{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181003-101564","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181003-101564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T08:45:01Z","timestamp":1709887501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/Mumps-in-Poland-in-2019,181003,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"alternative-id":["181003"],"URL":"https:\/\/doi.org\/10.32394\/pe.75.21","relation":{},"ISSN":["0033-2100","2545-1898"],"issn-type":[{"value":"0033-2100","type":"print"},{"value":"2545-1898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]}}}